Related Posts
Eculizumab (Brand Name: Soliris) 300...
In a significant move to...
Overview of Chronic Myelomonocytic Leukemia...
Nearly 20% of breast cancers...
On December 23, 2024, the...
Recent Posts
- FDA Approves Emcitate (Tiratricol): First Treatment for MCT8 Deficiency (Allan-Herndon-Dudley Syndrome)
- FDA Approves Isembyld (Apitegromab-mstn), First Muscle-Targeted Therapy for Spinal Muscular Atrophy
- FDA Approves First Drug to Treat Alexander Disease: Zanvastro (Zilganersen)
- कैंसर से पहले शरीर देता है ये 5 संकेत, न करें नज़रअंदाज़
- Trodelvy in India: A Sourcing Guide for Hospitals Treating Triple-Negative Breast Cancer